04/17/2024
4:19 PM | BENEVICH ERIC (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/15/2024
3:29 PM | BENEVICH ERIC (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/10/2024
3:40 PM | Neurocrine Biosciences (Filer)
| Form ARS | |
04/10/2024
3:31 PM | Neurocrine Biosciences (Filer)
| Form DEFA14A | |
04/10/2024
3:07 PM | Neurocrine Biosciences (Filer)
| Form DEF 14A | |
04/03/2024
3:44 PM | Delaet Ingrid (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2024
5:02 PM | Delaet Ingrid (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
03/21/2024
3:20 PM | Delaet Ingrid (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/15/2024
4:25 PM | MORROW GEORGE J (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
4:33 PM | BENEVICH ERIC (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
4:15 PM | Delaet Ingrid (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
4:19 PM | Neurocrine Biosciences (Issuer)
POPS RICHARD F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2024
3:32 PM | BENEVICH ERIC (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/14/2024
3:33 PM | MORROW GEORGE J (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/12/2024
5:47 PM | Neurocrine Biosciences (Issuer)
Neurocrine Biosciences (Issuer)
POPS RICHARD F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
5:38 PM | Delaet Ingrid (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
3:22 PM | Delaet Ingrid (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/08/2024
3:22 PM | Neurocrine Biosciences (Subject)
POPS RICHARD F (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024
5:55 PM | BENEVICH ERIC (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
6:02 PM | Delaet Ingrid (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
5:50 PM | Neurocrine Biosciences (Issuer)
Norwalk Leslie V (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
4:11 PM | Neurocrine Biosciences (Issuer)
POPS RICHARD F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
4:51 PM | Neurocrine Biosciences (Issuer)
ROBERTS EIRY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
4:40 PM | Gano Kyle (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
4:43 PM | GORMAN KEVIN CHARLES (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
4:45 PM | Lippoldt Darin (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
4:48 PM | Neurocrine Biosciences (Issuer)
Onyia Jude (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
4:27 PM | ABERNETHY MATT (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
4:29 PM | BENEVICH ERIC (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
4:33 PM | Boyer David W. (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
4:35 PM | Cooke Julie (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
4:38 PM | Delaet Ingrid (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
4:17 PM | GORMAN KEVIN CHARLES (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
3:18 PM | ABERNETHY MATT (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2024
3:19 PM | Lippoldt Darin (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2024
3:19 PM | Neurocrine Biosciences (Subject)
ROBERTS EIRY (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2024
3:20 PM | Boyer David W. (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2024
3:20 PM | GORMAN KEVIN CHARLES (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/09/2024
4:29 PM | Neurocrine Biosciences (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/08/2024
6:46 PM | Boyer David W. (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
6:35 PM | Cooke Julie (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
These AI trades triggered this morning (545% return) (Ad) If you think a market crash is possible in 2024, I don't know why you're not using this yet. Click Here To Get Your Free Copy |
02/08/2024
6:21 PM | GORMAN KEVIN CHARLES (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
6:25 PM | Lippoldt Darin (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
6:28 PM | Neurocrine Biosciences (Issuer)
ROBERTS EIRY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
6:12 PM | ABERNETHY MATT (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
6:15 PM | BENEVICH ERIC (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
6:17 PM | Gano Kyle (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
3:21 PM | Boyer David W. (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/08/2024
3:21 PM | Boyer David W. (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/07/2024
6:00 AM | Neurocrine Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/02/2024
6:21 PM | GORMAN KEVIN CHARLES (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
6:24 PM | Lippoldt Darin (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
6:26 PM | Neurocrine Biosciences (Issuer)
Onyia Jude (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
6:29 PM | Neurocrine Biosciences (Issuer)
ROBERTS EIRY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
6:00 PM | ABERNETHY MATT (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
6:05 PM | BENEVICH ERIC (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
6:07 PM | Boyer David W. (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
6:11 PM | Cooke Julie (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
6:14 PM | Delaet Ingrid (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
6:17 PM | Gano Kyle (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/01/2024
3:43 PM | Delaet Ingrid (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/31/2024
4:04 PM | Delaet Ingrid (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/24/2024
4:47 PM | Lippoldt Darin (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2024
10:52 AM | BlackRock Inc. (Filed by)
Neurocrine Biosciences (Subject)
| Form SC 13G/A | |
01/22/2024
3:17 PM | Lippoldt Darin (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/10/2024
3:31 PM | GORMAN KEVIN CHARLES (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
3:15 PM | GORMAN KEVIN CHARLES (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/04/2024
5:26 PM | Neurocrine Biosciences (Issuer)
RASTETTER WILLIAM H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
5:32 PM | Gano Kyle (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2024
3:31 PM | Neurocrine Biosciences (Subject)
RASTETTER WILLIAM H (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/02/2024
3:31 PM | Gano Kyle (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/27/2023
3:08 PM | Cooke Julie (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2023
3:10 PM | LYONS GARY A (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2023
3:15 PM | Neurocrine Biosciences (Issuer)
ROBERTS EIRY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/22/2023
3:21 PM | Cooke Julie (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/22/2023
3:22 PM | Neurocrine Biosciences (Subject)
ROBERTS EIRY (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/22/2023
3:22 PM | LYONS GARY A (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/14/2023
4:22 PM | Neurocrine Biosciences (Issuer)
ROBERTS EIRY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2023
5:18 PM | Neurocrine Biosciences (Issuer)
ROBERTS EIRY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/08/2023
6:09 PM | Neurocrine Biosciences (Issuer)
ROBERTS EIRY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/08/2023
5:23 PM | Lippoldt Darin (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2023
3:32 PM | Neurocrine Biosciences (Subject)
ROBERTS EIRY (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/06/2023
3:33 PM | Lippoldt Darin (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/05/2023
3:54 PM | LYONS GARY A (Reporting)
Neurocrine Biosciences (Issuer)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/01/2023
7:01 PM | LYONS GARY A (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/01/2023
4:41 PM | Neurocrine Biosciences (Issuer)
Onyia Jude (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/29/2023
3:36 PM | Lippoldt Darin (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/29/2023
3:12 PM | Neurocrine Biosciences (Subject)
Onyia Jude (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/13/2023
6:01 AM | Neurocrine Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/31/2023
6:01 AM | Neurocrine Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/31/2023
6:02 AM | Neurocrine Biosciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
These AI trades triggered this morning (545% return) (Ad) If you think a market crash is possible in 2024, I don't know why you're not using this yet. Click Here To Get Your Free Copy |
10/06/2023
8:00 AM | Neurocrine Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/05/2023
6:02 AM | Neurocrine Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/04/2023
4:07 PM | Boyer David W. (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/14/2023
3:51 PM | LYONS GARY A (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2023
3:09 PM | LYONS GARY A (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/12/2023
6:31 AM | Neurocrine Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/01/2023
3:36 PM | Boyer David W. (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/01/2023
3:31 PM | Lippoldt Darin (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/01/2023
3:16 PM | Cooke Julie (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
